Ocular motility dysfunction associated with chemotherapeutic agents.
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D015835:Ocular Motility Disorders / Q000139:chemically induced*
D000970:Antineoplastic Agents